Social Media Content Creators Fueling Unofficial Trade for Unlicensed Weight-Loss Medication

An underground economy for unapproved slimming drugs is propelled by social media fitness personalities and sellers on messaging platforms, based on recent findings.

Investigational Treatment Gaining Traction Online

The experimental drug, which is still in research studies, is being advertised by online personalities for its alleged fat-burning effects. Viewers are urged to contact these profiles privately for source information, while also receiving promotional offers.

Active Trade on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where groups with thousands of participants share “before and after” photos, administration instructions and claims of rapid UK delivery. Sellers market the substance there before directing buyers to other platforms for transactions.

Learning About Retatrutide

Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could help patients lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.

Healthcare Experts Express Worries

Nevertheless, doctors and pharmacists have cautions that the sale of what is still an unapproved drug in the UK is a cause for concern and could lead to users administering substances of uncertain source.

Several professionals said the demand for retatrutide could be linked to the increasing price of licensed slimming products such as Mounjaro.

Legal Status and Implementation

Selling retatrutide on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some content creators try to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still breach pharmaceutical, marketing, and consumer regulations, risking fines, legal action or prison.

Service Reaction and Material Removal

According to TikTok, the platform has removed problematic content and prohibited related keywords and query recommendations. The company stated it was dedicated to keeping the service secure and investing in enhancing enforcement strategies.

Online Marketplace Activities

Research also found groups with up to 9,000 participants marketing the experimental drug using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays groups with numerous of members, populated with photos of slimming results, positive reviews and step-by-step guides for preparing or injecting at residence.

Within minutes of entering one group, a vendor posted WhatsApp details, where the majority of transactions occur. The vendor sent an instruction manual and guaranteed delivery within 48 hours. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. None asked about body mass, medical conditions or past usage.

Product Details and Pricing

Within these groups, messages display black plastic packages with postal service labels, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at home with sterile water, or ready-to-use pens typically sold at 160 pounds for 20mg. When questioned how much time a pen should be used, sellers give contradictory answers ranging from a several days to “depends on your body”.

Service Oversight and Safety Measures

A spokesperson for Telegram said it actively monitored harmful content on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are injecting substances they cannot confirm. Although the science behind this drug is valid, these digital versions may not contain what they claim,” said Jason Murphy, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With prices increasing, patients are turning to social media. But fake treatments are highly risky. You cannot know what’s contained or whether the environment they were produced in was sterile,” she explained.

Her team has previously encountered patients injured by self-injection from unverified suppliers. “We understand the frustration, but buying from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be impure or incorrectly dosed.”

Producer Statement

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been reviewed or approved by any regulatory agency globally. “Consequently at this point no one can market [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a Lilly experimental product not yet approved … may expose patients to possibly significant medical dangers”.

Lori Watson
Lori Watson

Lena is a seasoned gaming expert with over a decade of experience in reviewing online casinos and sharing insights on player strategies.